Company profile
AmCad BioMed Corporation
AmCad BioMed Corporation has 3 AI-enabled medical devices on the FDA list. The first decision was on April 26, 2017 and the most recent on September 8, 2021 (AmCAD-UT). Its most common review panel is Radiology (3 devices).
3AI devices
2017First decision
2021Latest decision
1Specialties
Per year
201720182021